In comparison to the control group, patients with scleroderma have a significantly higher likelihood of displaying anti-TPO antibodies with hypothyroidism (3.4-fold) and anti-TPO or/and anti-Tg without hypothyroidism (3.1-fold) [57]. This evidence concerns the gene TG and scleroderma.